Chemopreventive agents-induced regression of azoxymethane-induced aberrant crypt foci with the recovery of hexosaminidase activity.
Tao
L
L
Department of Pathology, Center for Environmental Medicine, Medical College of Ohio, Toledo 43614, USA.
Li
K
K
Pereira
M A
MA
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D001397:Azoxymethane / Q000633:toxicity*; D002273:Carcinogens / Q000633:toxicity*; D003110:Colonic Neoplasms / Q000201:enzymology / Q000517:prevention & control*; D003474:Curcumin / Q000494:pharmacology*; D008297:Male; D011230:Precancerous Conditions / Q000201:enzymology / Q000517:prevention & control*; D051381:Rats; D011916:Rats, Inbred F344; D001619:beta-N-Acetylhexosaminidases / Q000378:metabolism*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016588:Anticarcinogenic Agents; D002273:Carcinogens; D001619:beta-N-Acetylhexosaminidases; D003474:Curcumin; D001397:Azoxymethane